World Preclinical Congress 2016 Highlights
Over 1,000 preclinical research participants united in Boston this June 2016 for World Preclinical Congress. The event brought together scientists from pharma, academia and technology companies who shared interesting perspectives on how to innovate traditional drug discovery.
June 14 Symposia
INSIGHTS ON INNOVATIVE APPROACHES TO TRANSFORM DRUG DISCOVERY
Anthony J. Coyle Ph.D., Chief Scientific Officer and Senior Vice President, Centers for Therapeutic Innovation, Pfizer Inc.
James Wilson, M.D., Ph.D., Professor of Medicine and Pediatrics, Perelman School of Medicine; Director, Orphan Disease Center and Director, Gene Therapy Program, University of Pennsylvania
INSIGHTS ON INNOVATIVE TECHNOLOGIES ENABLING PRECLINICAL RESEARCH
Matt Gevaert, Ph.D., CEO and Co-founder, KIYATEC
Amit Vasanji, Ph.D., CTO & CSO, ImageIQ
Tim Robertson, Ph.D., CEO, Vium, Inc.
In recent years, the World Preclinical Congress (WPC) has turned into a key networking event for those involved in preclinical research. It features conferences, training seminars and short courses that cover the very latest in preclinical strategies and technologies, to enable better and faster decisions in drug discovery. WPC attracts a diverse, global audience, which include experts, as well as people who are new and eager to contribute to the field. Having chemists, biologists, pharmacologists, toxicologists, screening and formulation experts in attendance, creates an interesting cross-disciplinary environment for tackling challenges and sharing expertise. Now in its 15th year the event will continue to highlight ways to improve accuracy and efficiency in preclinical research, while bringing together the people and technologies to make it happen.
As always, we ask those of you involved in preclinical work to try and help innovate traditional drug discovery by bringing along your ideas, showcasing new technologies, and fostering new collaborations. WPC is indeed the event “Where Preclinical Minds Meet Discovery Technologies” and we hope you can join this dynamic community to help shape the future of preclinical research!